136 related articles for article (PubMed ID: 1682659)
1. Mefloquine for multidrug-resistant malaria.
Luxemburger C; Nosten F; ter Kuiile F; Frejacques L; Chongsuphajaisiddhi T; White NJ
Lancet; 1991 Nov; 338(8777):1268. PubMed ID: 1682659
[No Abstract] [Full Text] [Related]
2. Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
Ezedinachi EN; Ekanem OJ; Chukwuani CM; Meremikwu MM; Ojar EA; Alaribe AA; Umotong AB; Haller L
Am J Trop Med Hyg; 1999 Jul; 61(1):114-9. PubMed ID: 10432067
[TBL] [Abstract][Full Text] [Related]
3. Open comparison of mefloquine, mefloquine/sulfadoxine/pyrimethamine and chloroquine in acute uncomplicated falciparum malaria in children.
Sowunmi A; Oduola AM
Trans R Soc Trop Med Hyg; 1995; 89(3):303-5. PubMed ID: 7660443
[TBL] [Abstract][Full Text] [Related]
4. Mefloquine--its 20 years in the Thai Malaria Control Program.
Wongsrichanalai C; Prajakwong S; Meshnick SR; Shanks GD; Thimasarn K
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):300-8. PubMed ID: 15691128
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
6. Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand.
Thimasarn K; Pinichpongse S; Malikul S; Rooney W; Tansophalaks S
Southeast Asian J Trop Med Public Health; 1990 Sep; 21(3):404-11. PubMed ID: 2075482
[TBL] [Abstract][Full Text] [Related]
7. Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
Salako LA; Adio RA; Walker O; Sowunmi A; Stürchler D; Mittelholzer ML; Reber-Liske R; Dickschat U
Ann Trop Med Parasitol; 1992 Dec; 86(6):575-81. PubMed ID: 1304698
[TBL] [Abstract][Full Text] [Related]
8. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam.
Trinh KA; Nguyen VK; Arnold K; Vo VC; Nguyen NB; Kim T; Ladinsky J
Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Faye B; Ndiaye JL; Ndiaye D; Dieng Y; Faye O; Gaye O
Malar J; 2007 Jun; 6():80. PubMed ID: 17570848
[TBL] [Abstract][Full Text] [Related]
10. In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia.
Thimasarn K; Sirichaisinthop J; Vijaykadga S; Tansophalaks S; Yamokgul P; Laomiphol A; Palananth C; Thamewat U; Tháithong S; Rooney W
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):204-12. PubMed ID: 8629047
[TBL] [Abstract][Full Text] [Related]
11. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
Peters PJ; Thigpen MC; Parise ME; Newman RD
Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
[TBL] [Abstract][Full Text] [Related]
12. Mefloquine-resistant falciparum malaria on the Thai-Burmese border.
Nosten F; ter Kuile F; Chongsuphajaisiddhi T; Luxemburger C; Webster HK; Edstein M; Phaipun L; Thew KL; White NJ
Lancet; 1991 May; 337(8750):1140-3. PubMed ID: 1674024
[TBL] [Abstract][Full Text] [Related]
13. In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia.
Denis MB; Kouznetsov RL; Giboda M
Folia Parasitol (Praha); 1991; 38(2):187-8. PubMed ID: 1937278
[No Abstract] [Full Text] [Related]
14. Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria.
Metzger W; Mordmüller B; Graninger W; Bienzle U; Kremsner PG
J Antimicrob Chemother; 1995 Oct; 36(4):723-8. PubMed ID: 8591949
[TBL] [Abstract][Full Text] [Related]
15. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
[TBL] [Abstract][Full Text] [Related]
16. Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria.
Reisinger EC; Horstmann RD; Dietrich M
Trans R Soc Trop Med Hyg; 1989; 83(4):474-7. PubMed ID: 2694482
[TBL] [Abstract][Full Text] [Related]
17. Mefloquine plus sulfadoxine and pyrimethamine.
Lancet; 1991 Jul; 338(8758):51-2. PubMed ID: 1676099
[No Abstract] [Full Text] [Related]
18. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
19. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
20. [The reliability and side effects of malaria chemoprophylaxis].
Steffen R; Heusser R
Schweiz Rundsch Med Prax; 1986 Apr; 75(16):446-8. PubMed ID: 2939527
[No Abstract] [Full Text] [Related]
[Next] [New Search]
